<i>In vivo</i> epigenetic editing of <i>sema6a</i> promoter reverses impaired transcallosal connectivity caused by <i>C11orf46/ARL14EP</i> neurodevelopmental risk gene
Cyril Peter(Allen Institute for Brain Science), Atsushi Kamiya(Johns Hopkins University)
Cited by 0
Related Papers
In vivo epigenetic editing of Sema6a promoter reverses transcallosal dysconnectivity caused by C11orf46/Arl14ep risk gene
|Nature Communications|2019|57
Single chromatin fiber profiling and nucleosome position mapping in the human brain
|Cell Reports Methods|2024|4